CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- 4 Open-market buy 10% owner bought 832,456 shares at $12,786,524.16 ($10,644,218,756,137)
- 4 Grant or award Director acquired 23,133 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award SVP and CFO acquired 102,471 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Sr. VP, Technical Operations gave up 3,261 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Research & Early Clin Dev gave up 3,261 shares (to pay taxes)
- 4 Shares withheld for taxes Sr VP, Gen. Counsel, Secretary gave up 3,261 shares (to pay taxes)
- 4 Shares withheld for taxes Sr VP, Chief Comm. Officer gave up 3,261 shares (to pay taxes)
- 4 Returned to the company Director returned 96,250 shares (to the company)
- 4 Grant or award President & CEO acquired 43,905 shares (grant or award)
- 4 Open-market sale Sr. VP, Technical Operations sold 53,424 shares at $22.50 ($1,202,040)
- 4 Open-market sale Sr VP, Gen. Counsel, Secretary sold 28,156 shares at an average $22.13 ($622,999)
- 4 Open-market buy 10% owner bought 172,651 shares at $3,912,271.66 ($675,457,614,371)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Sr. VP, Corp. Partnerships acquired 10,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 62,403 shares (grant or award)
- 4 Grant or award Sr VP, Gen. Counsel, Secretary acquired 28,365 shares (grant or award)
- 4 Grant or award SVP, Research & Early Clin Dev acquired 28,365 shares (grant or award)
Page 15 of 39 · 776 filings